Tyramine
|
Basic information |
| Metabolite name | Tyramine |
 | HMDB0000306 |
 |
C00483 |
 |
5610 |
| Synonyms | NA |
| No. of studies | 16 |
|
Basic information |
| Metabolite name | Tyramine |
| HMDB0000306 |
|
C00483 |
|
5610 |
| Synonyms | NA |
| No. of studies | 16 |
|
Relationship between Tyramine and depression (count: 16) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M003 | Type1 | day 9 CUMS group vs. control group | Urine | Sprague-Dawley rat | Up |
| Study M003 | Type1 | day 27 CUMS group vs. control group | Urine | Sprague-Dawley rat | Up |
| Study M018 | Type1 | CUMS group vs. control group | Urine | Sprague-Dawley rat | Up |
| Study M069 | Type1 | CUMS group vs. control group | Urine | Sprague-Dawley rat | Down |
| Study M096 | Type1 | CUMS group vs. control group | Prefrontal cortex | Wistar rat | Up |
| Study M096 | Type2 | CUMS + paroxetine group vs. CUMS group | Prefrontal cortex | Wistar rat | Down |
| Study M101 | Type1 | CSD group vs. control group | Faece | C57BL/6 mouse | Down |
| Study M1105 | Type1 | psychological stress group vs. control group | Faece | C57BL/6 J mouse | Up |
| Study M137 | Type1 | CUMS group vs. control group | Urine | Sprague-Dawley rat | Up |
| Study M137 | Type2 | CUMS + hypericin group vs. CUMS group | Urine | Sprague-Dawley rat | Down |
| Study M137 | Type2 | CUMS + venlafaxine group vs. CUMS group | Urine | Sprague-Dawley rat | Down |
| Study M207 | Type1 | depressed group vs. control group | Faece | Kunming mouse | Up |
| Study M483 | Type1 | depression group vs. control group | Plasma | Human | Up |
| Study M582 | Type2 | CUMS + fluoxetine group vs. CUMS group | Serum | C57BL/6N mouse | Down |
| Study M582 | Type3 | control + fluoxetine group vs. control group | Serum | C57BL/6N mouse | Down |
| Study M651 | Type1 | LPS group vs. control group | Brain | C57BL/6 mouse | Up |
| Study M769 | Type1 | CSDS group vs. control group | Amygdala | Sprague-Dawley rat | Up |
| Study M783 | Type1 | stroke + CUMS group vs. stroke group | Faece | Sprague-Dawley rat | Up |
| Study M846 | Type2 | postpartum depression model + 919 syrup group vs. postpartum depression model group | Hippocampus | BALB/c mouse | Down |
| Study M850 | Type1 | reserpine group vs. control group | Brain | C57BL/6 mouse | Up |
| Study M908 | Type3 | post-ketamine treatment vs. baseline | Plasma | Human | Up |